Editas: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $18.9 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of 23 cents per share.

The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.

The genome editing company posted revenue of $60 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $13.4 million.

For the year, the company reported a loss of $153.2 million, or $2.02 per share. Revenue was reported as $78.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT

Advertisement

Recommended Stories